APR 8·BD NewsroomMed
BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
BD (Becton, Dickinson and Company) announced the CE Mark application for its Liverty™ TIPS Stent Graft, introducing a next-generation, adjustable-diameter device for portal hypertension care in the European Union. This innovation aims to expand treatment options for patients with advanced liver disease and cirrhosis. Safety and effectiveness data from the pivotal ARCH clinical trial for the Liverty™ TIPS Stent Graft will be presented for the first time at the Society of Interventional Radiology Annual Scientific Meeting on April 12, 2026.